Literature DB >> 33945033

Fingolimod in pediatric-onset multiple sclerosis.

Mauro Zaffaroni1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33945033     DOI： 10.1007/s10072-021-05294-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  17 in total

1.  Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years.

Authors:  L A Benson; B C Healy; M P Gorman; N F Baruch; T Gholipour; A Musallam; T Chitnis
Journal:  Mult Scler Relat Disord       Date:  2013-07-12       Impact factor: 4.339

Review 2.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 3.  Pediatric multiple sclerosis: Conventional first-line treatment and general management.

Authors:  Angelo Ghezzi; Maria Pia Amato; Naila Makhani; Teri Shreiner; Jutta Gärtner; Silvia Tenembaum
Journal:  Neurology       Date:  2016-08-30       Impact factor: 9.910

Review 4.  Multiple Sclerosis.

Authors:  Daniel S Reich; Claudia F Lucchinetti; Peter A Calabresi
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

5.  Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

Authors:  Mark P Gorman; Brian C Healy; Mariann Polgar-Turcsanyi; Tanuja Chitnis
Journal:  Arch Neurol       Date:  2009-01

6.  Natural history of multiple sclerosis with childhood onset.

Authors:  Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

7.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

Authors:  C Confavreux; G Aimard; M Devic
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

8.  Incidence of acquired demyelination of the CNS in Canadian children.

Authors:  B Banwell; J Kennedy; D Sadovnick; D L Arnold; S Magalhaes; K Wambera; M B Connolly; J Yager; J K Mah; N Shah; G Sebire; B Meaney; M-E Dilenge; A Lortie; S Whiting; A Doja; S Levin; E A MacDonald; D Meek; E Wood; N Lowry; D Buckley; C Yim; M Awuku; C Guimond; P Cooper; F Grand'Maison; J B Baird; V Bhan; A Bar-Or
Journal:  Neurology       Date:  2009-01-20       Impact factor: 9.910

9.  Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.

Authors:  Michael Absoud; Ming J Lim; Wui K Chong; Christian G De Goede; Katharine Foster; Roxana Gunny; Cheryl Hemingway; Philip E Jardine; Rachel Kneen; Marcus Likeman; Ken K Nischal; Michael G Pike; Naomi A Sibtain; William P Whitehouse; Carole Cummins; Evangeline Wassmer
Journal:  Mult Scler       Date:  2012-04-19       Impact factor: 6.312

Review 10.  Pediatric multiple sclerosis: a review.

Authors:  Raed Alroughani; Alexey Boyko
Journal:  BMC Neurol       Date:  2018-03-09       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.